Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

AAREY DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.349.24-25.6820.5517.58

What is the latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS is 11.34 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202511.34
Mar20249.24
Mar2023-25.68
Mar202220.55
Mar202117.58

How is Core EBITDA Growth of AAREY DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 11.34
22.73
Mar2024 9.24
Positive
Mar2023 -25.68
Negative
Mar2022 20.55
16.89
Mar2021 17.58 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹191.5 Cr 2.1% 1.9% 36.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 5.5% -0.2% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

2.1%

1.9%

36.2%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses